Question

Is stem cell therapy for Cerebral Palsy FDA-approved?

No generic stem-cell therapy is FDA-approved for cerebral palsy. A cord-blood bank, registered study, hospital or laboratory credential does not constitute product approval for this indication.

Medical review statusPending clinical sign-offLast evidence update: 2026-08-05Methodology and editorial standards
Clinical review team: Dr Kamelia Milcheva, Hematologist · Dr Vadym Uvarov, Board-Certified Physician · Hepatobiliary Surgeon · Candidate of Medical SciencesEditorial responsibility: StemCellAtlas research teamEducational information only. This page does not provide medical advice, diagnosis or a treatment recommendation.

How stem cells are studied for Cerebral Palsy

Cerebral palsy describes permanent disorders of movement and posture caused by disturbance in the developing brain; needs and associated conditions vary widely. Cell research has explored cord-blood and other products as possible modulators of inflammation or plasticity, usually alongside rehabilitation. These hypotheses do not mean that established brain injury is reversed or that different cell sources are equivalent.

Am I a candidate? → · Cerebral Palsy: full overview → · Cerebral Palsy cost → · Cost →

Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.

Sources & further reading

Explore all sections · Data & downloads

Compare cell-therapy evidence, registered studies and published price observations.

StemCellAtlas is a source-first research and cost-planning guide. It separates registry and regulator evidence from heterogeneous commercial observations.

Request written information